| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | de Blic J | |
| Scheinmann P | |||
| Pham-Thi N | |||
| P2860 | cites work | Safety of sublingual-swallow immunotherapy in children and adults | Q33870761 |
| Allergic rhinitis and its impact on asthma | Q34438438 | ||
| Immune mechanisms of allergen-specific sublingual immunotherapy | Q34484071 | ||
| Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis | Q35970094 | ||
| The safety of sublingual-swallow immunotherapy: an analysis of published studies | Q36130311 | ||
| Sublingual immunotherapy: efficacy--methodology and outcome of clinical trials | Q36515397 | ||
| Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study | Q39581669 | ||
| Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis | Q40523833 | ||
| Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis | Q40523843 | ||
| Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study | Q43646876 | ||
| Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate | Q44680424 | ||
| Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more | Q45088211 | ||
| Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy. | Q46714664 | ||
| Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma | Q46930354 | ||
| Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study | Q47776229 | ||
| Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years | Q47795423 | ||
| Safety of sublingual immunotherapy in children with asthma. | Q51646876 | ||
| Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. | Q51686636 | ||
| A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. | Q52942005 | ||
| Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. | Q53551598 | ||
| Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study | Q72996277 | ||
| Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial | Q73297911 | ||
| Immunomodulation during sublingual therapy in allergic children | Q73481524 | ||
| Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis | Q78144641 | ||
| Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy | Q79917788 | ||
| Quantitative assessment of the adherence to sublingual immunotherapy | Q80235451 | ||
| Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract | Q81454014 | ||
| Children's compliance with allergen immunotherapy according to administration routes | Q81595002 | ||
| Allergen immunotherapy in early childhood: between Scylla and Charybdis! | Q81755613 | ||
| Sublingual immunotherapy and regulatory T cells | Q82709272 | ||
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 7-10 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Allergy | Q2699825 |
| P1476 | title | Sublingual immunotherapy in the treatment of children | |
| P478 | volume | 61 Suppl 81 |
| Q59737295 | Consenso sobre tratamiento del asma en pediatría |
| Q43515187 | Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial |
| Q36789966 | Further marches: allergic and non-allergic |
| Q37304729 | Subcutaneous and sublingual immunotherapy in children: complete update on controversies, dosing, and efficacy |
| Q36583727 | Sublingual immunotherapy of allergic diseases |
Search more.